DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
R••••••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: Equity Securities
What matters now
- 64¢ → 74¢consensus mark
Consensus mark 74¢ on cost, up from 64¢ a year ago, 66¢ last quarter.
Q2 2026 · The lenders' own valuations moved back up.
Derived1 of 1 lender' own marks, weighted by principal - $4.48Mprincipal outstanding
$4.48M principal held by 1 lender; matures Jul 2028.
Q2 2026 · Refinancing is due in 22 months at a 74¢ mark.
FactBDC schedules of investments, 30 Jun 2026; a sum of the BDCs' pieces, a lower bound
Mark path, consensus per quarter end
64¢ · 66¢ · 65¢ · 66¢ · 74¢Q2 2025 to Q2 2026
Principal held
at least $4.5M
sum of BDC pieces, a lower bound
Fair value
$3.3M
74c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
1 equity pieces beside them
Next maturity
Jul 21, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
9
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• C••••• B•• I••• | $4.48M | 74¢ | +8 pts |
Every BDC piece · 4 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment T••• U••••••••• T••• L••• I•••• S+ S••••• 2.50%, 3.25% PIK I••••••• R••• 9.48% | $4.3M | $3.1M 74c | SOFR+250 bp PIK 3.25% |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• U••••••••• R••••••• I•••• S+ S••••• 2.50%, 3.25% PIK I••••••• R••• 9.48% A | $218,322 | $160,216 73c | SOFR+250 bp PIK 3.25% |
| A•••• C••••• B•• I••• | equity equity Investment T••• C•••• A-1 U•••• A••••••••• D••• 7/22/2022 | Not disclosed | $0 0c | |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• S••••• S•••••• R•••••••• L••• I•••• S+ S••••• 2.50% I••••••• R••• 6.18% M• | Not disclosed | Not disclosed | SOFR+250 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $4.3M | 74c | SOFR+250 bp PIK 3.25% | Jul 21, 2028 | 1 |
| first lien revolver first lien | at least $218,322 | 73c | SOFR+250 bp PIK 3.25% | Jul 21, 2028 | 1 |
Equity pieces beside the debt: equity ($0 fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $4.5M | $3.3M | 74c | 2 |
| Mar 31, 2026 | 1 | $4.5M | $2.9M | 66c | 2 |
| Dec 31, 2025 | 1 | $4.4M | $2.8M | 65c | 2 |
| Sep 30, 2025 | 1 | $4.3M | $2.8M | 66c | 2 |
All 14 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 1 | $4.5M | $2.9M | 64c | 0 |
| Mar 31, 2025 | 1 | $4.4M | $2.7M | 62c | 0 |
| Dec 31, 2024 | 1 | $8.8M | $5.8M | 67c | 0 |
| Sep 30, 2024 | 1 | $4.3M | $3.0M | 71c | 0 |
| Jun 30, 2024 | 1 | $4.2M | $2.9M | 71c | 0 |
| Mar 31, 2024 | 1 | $4.6M | $4.3M | 94c | 0 |
| Dec 31, 2023 | 1 | $9.5M | $8.9M | 95c | 0 |
| Sep 30, 2023 | 1 | $4.3M | $4.2M | 100c | 0 |
| Jun 30, 2023 | 1 | $4.3M | $4.2M | 99c | 0 |
| Dec 31, 2022 | 1 | $4.3M | $4.2M | 99c | 0 |
What changed
- Mark recoveredJun 30, 2026
- Mark recoveredJun 30, 2026
- Spread changed (observed)Sep 30, 2025
- PIK interest appearsSep 30, 2025
- Spread changed (observed)Sep 30, 2025
Full timeline · 16 eventsShow fewer
- PIK interest appearsSep 30, 2025
- PIK interest appearsSep 30, 2025
- PIK interest appearsSep 30, 2025
- Maturity shortened (observed)Sep 30, 2025
- Maturity extended (observed)Jun 30, 2025
- Maturity extended (observed)Jun 30, 2025
- Maturity shortened (observed)Mar 31, 2025
- Maturity extended (observed)Dec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Marked down across lendersJun 30, 2024
- Marked down (one lender)Jun 30, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- REVHEALTHderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it